Diagnosis of primary HIV-1 infection

被引:139
作者
Daar, ES
Little, S
Pitt, J
Santangelo, J
Ho, P
Harawa, N
Kerndt, P
Giorgi, JV
Bai, JX
Gaut, P
Richman, DD
Mandel, S
Nichols, S
机构
[1] Univ Calif Los Angeles, Sch Med, Cedars Sinai Burns & Allen Res Inst, Los Angeles Cty HIV Epidemiol Program, Los Angeles, CA USA
[2] Los Angeles Free Clin, Los Angeles, CA USA
[3] Ctr AIDS Res, Los Angeles, CA USA
[4] Univ Calif San Diego, San Diego, CA 92103 USA
[5] San Diego Vet Affairs Healthcare Syst, San Diego, CA USA
关键词
D O I
10.7326/0003-4819-134-1-200101020-00010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The optimal approach for diagnosing primary HIV-1 infection has not been defined. Objective: To determine the usefulness of symptoms and virologic tests for diagnosing primary HIV-1 infection. Design: Prospective cohort study. Setting: A teaching hospital in Los Angeles and a university research center in San Diego, California. Patients: 436 patients who had symptoms consistent with primary HIV infection. Measurements: Clinical information and levels of HIV antibody, HIV RNA, and p24 antigen. Results: Primary infection was diagnosed in 54 patients (12.4%). The sensitivity and specificity of the p24 antigen assay were 88.7% (95% CI, 77.0% to 95.7%) and 100% (CI, 99.3% to 100%), respectively. For the HIV RNA assay, sensitivity was 100% and specificity was 97.4% (CI, 94.9% to 98,9%), Fever, myalgia, rash, night sweats, and arthralgia occurred more frequently in patients with primary infection (P < 0.05). Conclusions: No sign or symptom allows targeted screening for primary infection. Although assays for HIV RNA are more sensitive than those for p24 antigen in diagnosing primary infection, they are more expensive and are more likely to yield false-positive results.
引用
收藏
页码:25 / 29
页数:5
相关论文
共 15 条
[1]  
[Anonymous], [No title captured]
[2]   Risk factors and clinical preservation of acute primary HIV infection in India [J].
Bollinger, RC ;
Brookmeyer, RS ;
Mehendale, SM ;
Paranjape, RS ;
Shepherd, ME ;
Gadkari, DA ;
Quinn, TC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (23) :2085-2089
[3]   TRANSIENT HIGH-LEVELS OF VIREMIA IN PATIENTS WITH PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
DAAR, ES ;
MOUDGIL, T ;
MEYER, RD ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :961-964
[4]  
ERICE A, 2000, 7 C RETR OPP INF SAN
[5]  
*FDN RETR HUM HLTH, 1999, 6 C RETR OPP INF CHI
[6]   DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 P24 ANTIGEN AND PLASMA RNA - RELEVANCE TO INDETERMINATE SEROLOGIC TESTS [J].
HENRARD, DR ;
PHILLIPS, J ;
WINDSOR, I ;
FORTENBERRY, D ;
KORTE, L ;
FANG, C ;
WILLIAMS, AE .
TRANSFUSION, 1994, 34 (05) :376-380
[7]  
JACQUEZ JA, 1994, J ACQ IMMUN DEF SYND, V7, P1169
[8]   Acute human immunodeficiency virus type 1 infection [J].
Kahn, JO ;
Walker, BD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (01) :33-39
[9]   RAPID AND SIMPLE PCR ASSAY FOR QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA IN PLASMA - APPLICATION TO ACUTE RETROVIRAL INFECTION [J].
MULDER, J ;
MCKINNEY, N ;
CHRISTOPHERSON, C ;
SNINSKY, J ;
GREENFIELD, L ;
KWOK, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (02) :292-300
[10]   Zidovudine treatment in patients with primary (Acute) human immunodeficiency virus type 1 infection: A randomized, double-blind, placebo-controlled trial [J].
Niu, MT ;
Bethel, J ;
Holodniy, M ;
Standiford, HC ;
Schnittman, SM .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (01) :80-91